1. Home
  2. NVR vs RPRX Comparison

NVR vs RPRX Comparison

Compare NVR & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$6,460.51

Market Cap

17.9B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$49.69

Market Cap

19.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVR
RPRX
Founded
1980
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9B
19.5B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NVR
RPRX
Price
$6,460.51
$49.69
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$7,157.80
$51.40
AVG Volume (30 Days)
15.5K
2.5M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
N/A
EPS
436.55
1.78
Revenue
$10,323,959,000.00
$2,378,193,000.00
Revenue This Year
N/A
$38.63
Revenue Next Year
$6.60
$4.73
P/E Ratio
$14.97
$27.69
Revenue Growth
N/A
5.06
52 Week Low
$6,301.03
$31.97
52 Week High
$8,618.28
$50.08

Technical Indicators

Market Signals
Indicator
NVR
RPRX
Relative Strength Index (RSI) 40.68 63.01
Support Level $6,301.03 $35.34
Resistance Level $7,778.36 $50.08
Average True Range (ATR) 191.57 0.89
MACD -14.68 0.01
Stochastic Oscillator 7.44 88.17

Price Performance

Historical Comparison
NVR
RPRX

About NVR NVR Inc.

NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: